Plasma cardiotrophin-1 is elevated in human hypertension and stimulated by ventricular stretch

被引:61
作者
Pemberton, CJ [1 ]
Raudsepp, SD [1 ]
Yandle, TG [1 ]
Cameron, VA [1 ]
Richards, AM [1 ]
机构
[1] Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Med, Cardioendocrine Res Grp, Christchurch, New Zealand
关键词
cytokines; hypertension; secretion; ventricular stretch; HPLC;
D O I
10.1016/j.cardiores.2005.05.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Cardiotrophin-1 (CT-1) is an interleukin-6-related cytokine with known hypertrophic and protective actions upon cardiac myocytes. We provide here the first report of cardiac tissue and plasma levels of CT-1 in human and experimental hypertension, demonstrate cardiac CT-1 secretion stimulated by ventricular stretch, and characterise Molecular forms of CT-1 in tissue and plasma. Methods: CT-1 levels in human and rat plasma and in rat cardiac tissue extracts were determined by specific radioimmunoassay (RIA). Cardiac CT-1 secretion during ventricular stretch was studied in isolated, perfused hearts. Molecular forms of CT-1 were identified using RIA coupled with high performance liquid chromatography (HPLC). Results are given as mean +/- SEM. Results: Plasma levels of CT-1 in patients with untreated hypertension (UTH, 606 +/- 18 pmol/L, n = 24) were significantly higher than those in age-and BMI-matched normotensive volunteers (NT, 546 +/- 12 pmol/L, n=31, P < 0.01 vs. UTH). CT-1 levels in matched patients with treated hypertension (THT, 618 +/- 10 pmol/L, n=35) were similar to those in UTH patients, but higher than in NT controls (P < 0.01). Plasma CT-1 demonstrated a weak but significant correlation with systolic blood pressure in all patients (r = 0.241, P < 0.05, n = 90). In contrast, CT-1 levels in male, 40-week-old, NT-WKY rats (1295 +/- 98 pmol/L) were significantly higher than those in matched UTH-SHR (937 +/- 31 pmol/L, P < 0.01). In both WKY and SHR rats, atrial tissue concentrations of CT-1 were 8-fold higher than ventricular levels. Left ventricular tissue CT-1 protein concentrations were significantly higher in 40-week-old SHR compared with age-matched WKY (SHR 12.6 +/- 0.5 fmol/g vs. WKY 9.5 +/- 0.8 fmol/g, P < 0.01). Ventricular stretch of Langendorff perfused, isolated WKY/SHR hearts resulted insignificant, acute release of CT-1 and BNP. HPLC coupled with specific RIA revealed CT-1 in human/rat plasma, isolated rat heart perfusate, and rat heart tissue extracts to consist of complex, high molecular weight forms. Conclusions: This is the first report to show increased levels of plasma CT-1 in hypertensive disease. CT-1 is a unique cardiac cytokine whose release is stimulated by ventricular stretch. The atrium contains the highest levels of the protein. The stored and circulating molecular form of CT-1 is complex, which may modulate its in vivo role in cardiovascular disease. (c) 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:109 / 117
页数:9
相关论文
共 41 条
[1]   Augmented expression of cardiotrophin-1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat [J].
Aoyama, T ;
Takimoto, Y ;
Pennica, D ;
Inoue, R ;
Shinoda, E ;
Hattori, R ;
Yui, Y ;
Sasayama, S .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2000, 32 (10) :1821-1830
[2]   Human recombinant resistin protein displays a tendency to aggregate by forming intermolecular disulfide linkages [J].
Aruna, B ;
Ghosh, S ;
Singh, AK ;
Mande, SC ;
Srinivas, V ;
Chauhan, R ;
Ehtesham, NZ .
BIOCHEMISTRY, 2003, 42 (36) :10554-10559
[3]   The heart is a source of circulating cardiotrophin-1 in humans [J].
Asai, S ;
Saito, Y ;
Kuwahara, K ;
Mizuno, Y ;
Yoshimura, M ;
Higashikubo, C ;
Tsuji, T ;
Kishimoto, I ;
Harada, M ;
Hamanaka, I ;
Takahashi, N ;
Yasue, H ;
Nakao, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 279 (02) :320-323
[4]   Blood pressure and inflammation in apparently healthy men [J].
Chae, CU ;
Lee, RT ;
Rifai, N ;
Ridker, PM .
HYPERTENSION, 2001, 38 (03) :399-403
[5]   Rat models of hypertension, cardiac hypertrophy and failure [J].
Doggrell, SA ;
Brown, L .
CARDIOVASCULAR RESEARCH, 1998, 39 (01) :89-105
[6]   Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: Implications for early atherosclerosis [J].
Furumoto, T ;
Saito, N ;
Dong, J ;
Mikami, T ;
Fujii, S ;
Kitabatake, A .
HYPERTENSION RESEARCH, 2002, 25 (03) :475-480
[7]   Cardiotrophin-1 protects the human myocardium from ischemic injury:: Comparison with the first and second window of protection by ischemic preconditioning [J].
Ghosh, S ;
Ng, LL ;
Talwar, S ;
Squire, IB ;
Galiñanes, M .
CARDIOVASCULAR RESEARCH, 2000, 48 (03) :440-447
[8]   Direct left ventricular wall stretch activates GATA4 binding in perfused rat heart: involvement of autocrine/paracrine pathways [J].
Hautala, N ;
Tenhunen, O ;
Szokodi, I ;
Ruskoaho, H .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2002, 443 (03) :362-369
[9]   A heart-specific increase in cardiotrophin-1 gene expression precedes the establishment of ventricular hypertrophy in genetically hypertensive rats [J].
Ishikawa, M ;
Saito, Y ;
Miyamoto, Y ;
Harada, M ;
Kuwahara, K ;
Ogawa, E ;
Nakagawa, O ;
Hamanaka, I ;
Kajiyama, N ;
Takahashi, N ;
Masuda, I ;
Hashimoto, T ;
Sakai, O ;
Hosoya, T ;
Nakao, K .
JOURNAL OF HYPERTENSION, 1999, 17 (06) :807-816
[10]   Augmented cardiac cardiotrophin-1 in experimental congestive heart failure [J].
Jougasaki, M ;
Tachibana, I ;
Luchner, A ;
Leskinen, H ;
Redfield, MM ;
Burnett, JC .
CIRCULATION, 2000, 101 (01) :14-17